Know what the FDA thinks
Rhizome's built an AI regulatory coworker that helps life sciences know what their regulator thinks. We're backed by the same investors as Benchling and have gone from 0 -> >25 customers in the last 18 months. We've indexed >3 TB worth of data put out by the FDA, EMA, MHRA, PMDA, etc., and built an agent that helps you: - automate precedents research - research FDA expectations around clinical endpoints, trial design, labeling, etc. - review briefing booklets, write pre-IND meeting packages, create white papers on almost any topic There's a few things that separate it from general AI tools: - each fact is backed by a citation, each citation is backed by the page of a health authority document - much more comprehensive answers, as our AI goes up to 1,000 sources - we've had no hallucinations reported last 18 months For more info, read rhizomeai.com/llms.txt For support, reach out to support@rhizomeai.com
Marka lagu xidho Rhizome AI, ChatGPT waxa laga yaabaa inuu abkan la wadaago wada-sheekeysiyo iyo xusuus khuseeya si uu macne guud ugu bixiyo codsiyadaada. Isticmaalka Rhizome AI ee xogtan waxa xukuma shuruudahooda iyo siyaasaddooda asturnaanta. Haddii Xusuusta kuu daaran tahay, xogta abka waxa loo adeegsan karaa in si firfircoon laguu siiyo macluumaad ama talo soo jeedin waxtar leh. ChatGPT had iyo jeer wuu ixtiraamaa dookhyadaada xogta tababarka, oo ay ku jirto xogta abyada ku xidhan. Adeegsiga abyada waxa la socon kara khatar sare. Waxaad maamuli kartaa dookhyadaada ama ka goyn kartaa abyada wakhti kasta setinkaaga. Wax badan ka ogow